Galvani Bioelectronics
Gerald Hunsberger is an experienced investigator in disease biology at Galvani Bioelectronics, specializing in bioelectronics for respiratory conditions such as asthma and pulmonary arterial hypertension. Expertise includes conducting ex vivo compound action potential recordings, assessing bronchopulmonary selectivity of electrical stimuli, and supporting preclinical development for novel disease targets. Previously, at GlaxoSmithKline, Hunsberger contributed significantly as a project scientist and investigator in respiratory therapeutic areas, leading optimization projects that resulted in key drug candidates for COPD and chronic cough. With a strong background in electrophysiology and pharmacological characterization, Hunsberger's research has led to innovative methodologies for evaluating small molecule modulators and ion channel targets. Academic credentials include a B.Sc. in Biomedical Engineering from Drexel University.
This person is not in any teams
This person is not in any offices
Galvani Bioelectronics
Galvani Bioelectronics is a joint venture between GSK and Verily Life Sciences. Galvani is devoted to the development of life-changing neuromodulation therapies for patients with chronic diseases.